Olam Group Limited (FRA:K25)
0.6700
-0.0050 (-0.74%)
At close: Jul 30, 2025, 10:00 PM CET
Intra-Cellular Therapies Revenue
In the year 2024, Olam Group had annual revenue of 56.26B SGD with 16.27% growth. Olam Group had revenue of 29.29B in the half year ending December 31, 2024, with 10.50% growth.
Revenue
56.26B SGD
Revenue Growth
+16.27%
P/S Ratio
0.07
Revenue / Employee
1.42M SGD
Employees
39,560
Market Cap
2.66B USD
Revenue Chart
* This company reports financials in SGD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 56.26B | 7.87B | 16.27% |
Dec 31, 2023 | 48.39B | -6.60B | -12.00% |
Dec 31, 2022 | 54.99B | 7.93B | 16.84% |
Dec 31, 2021 | 47.07B | 11.18B | 31.17% |
Dec 31, 2020 | 35.88B | 2.84B | 8.58% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.89B |
Siemens Aktiengesellschaft | 77.82B |
Deutsche Telekom AG | 120.25B |
Allianz SE | 109.03B |
Siemens Energy AG | 37.44B |
Rheinmetall AG | 10.48B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
Deutsche Bank Aktiengesellschaft | 30.07B |